Home   |   Press   |   Contact   |   Sitemap   

EMBL Technology Fund GmbH & Co. KG, Heidelberg

The European Molecular Biology Laboratory (EMBL) set up a fund specifically to preferably finance spin-offs from its own scientific research operations. The fund size is 25.6m. ETF is BSV II's only fund-in-fund investment.

- Dr. Stefan Herr (Managing Partner)
- Dr. Jan Adams (Managing Partner)

Investment Manager:
- Dr. Christoph Kronabel (Investment Committee)

Weitere Investoren:
- Aurelia
- Coral BioNet
- European Investment Fund
- EMBL Enterprise Management Technology Transfer
- HBM BioVentures
- K/S Danish Bioventure
- Private Investors